Arcadia Biosciences, Inc. — Director's Dealing 2018

Jun 9, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2018-06-06

Reporting Person: Murray Lilian Shackelford (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-06	Common Stock (right to buy)	$10.80	A	6408	Acquired	2028-06-06	Common Stock (6408)	Direct

Footnotes

F1: The option vests in three equal installments occurring on the first, second and third anniversary of the date of grant.